Consolidated Biosciences ApS: Financial statements 2024
CVR: 40180230
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Consolidated Biosciences ApS (CVR 40180230) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -49,125 and a net result of DKK -1,740,301 compared with DKK -1,719,344 the year before. Equity in the 2024 report amounted to DKK 2,017,350. The solvency ratio was 1.8%.
- Gross Profit
- DKK -49,125
- Profit/Loss
- DKK -1,740,301
- Equity
- DKK 2,017,350
- Total Assets
- DKK 111,853,295
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -49K | -1.7M | 2M | - |
| 2023 | - | -54K | -1.7M | 1.3M | - |
| 2022 | - | -46K | -1M | 3M | - |
| 2021 | - | -34K | -1.1M | -1M | - |
| 2020 | - | -43K | -585K | 65K | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Consolidated Biosciences ApS has published its annual report for 2023. Gross profit came to DKK -54,375, and the net result was DKK -1,719,344.
About Consolidated Biosciences ApS
Consolidated Biosciences ApS is a Danish company of the type Anpartsselskab based in Vedbæk, founded in 2019. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Lone Schøtt Kunøe. The company is owned by CENTRAL EUROPEAN FOOD PRODUCTION COMPANY ApS, CONSOLIDATED HOLDINGS A/S and L1 HOLDING ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -52,501 and a net result of DKK -1,814,488 compared with DKK -1,740,301 the year before. Equity in the 2025 report amounted to DKK 202,862.